October 30, 2019
8,798
415
76
5.58%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:13Now PlayingSign up for Top Class Actions' FREE weekly newsletter
The Food and Drug Administration (FDA) announced in February 2019 that it was requiring a Boxed Warning to be added to the Uloric (febuxostat) prescribing information after a clinical trial showed that Uloric was linked to an increased risk of death and an increased risk of death from all causes. The FDA first issued a safety announcement about this possible risk in late 2017 after a study linked Uloric to an increase in heart-related deaths. The study compared Uloric to allopurinol, another gout medication. Ring of Fire’s Farron Cousins discusses this with Scott Hardy, President of Top Class Actions.
Become a member today!
Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!
Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content!
Support Ring of Fire by subscribing to our YouTube channel
Be sociable! Follow us on:
Follow more of our stories at
Subscribe to our podcast
#rof #trofire #theringoffire #progressivenews
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.